Clinical Trial Site

Kansas City, Kansas 66160

4 studies enrolling now · 7 studies all time

What they study most

ANCA-Associated Vasculitis, ATTR Amyloidosis, Dermatomyositis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Transthyretin Amyloidosis With Cardiomyopathy, Transthyretin-Mediated Amyloidosis

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) — Recruiting now
• A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis — Running, not enrolling
• APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) — Completed
• A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Enrolling by invitation
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed